What is Elixir Research Group?
Headquartered in the heart of the world's largest medical district in Houston, Elixir Research Group operates as a specialized clinical trial facilitator. The company bridges the gap between pharmaceutical sponsors and patient populations, ensuring rigorous adherence to complex study protocols and aggressive recruitment timelines. Their market position is defined by a commitment to operational excellence in the testing of medical devices and novel therapeutics, serving as a critical node in the drug development lifecycle. By maintaining high-fidelity partnerships with sponsors, the group ensures that clinical data integrity remains at the forefront of their service delivery model.
How much funding has Elixir Research Group raised?
Elixir Research Group has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
Key Investors in Elixir Research Group
PPP
Public-Private Partnership
What's next for Elixir Research Group?
With the infusion of this recent investment, Elixir Research Group is expected to scale its site infrastructure and enhance its technological capabilities for patient recruitment. The strategic focus will likely shift toward optimizing trial throughput and expanding the scope of their therapeutic expertise. As the firm matures through its current growth phase, the emphasis will remain on maintaining the high standards required for regulatory compliance while scaling operations to meet the increasing demand for outsourced clinical research services. This capital deployment serves as a foundation for long-term sustainability and market leadership in the clinical trial sector.
See full Elixir Research Group company page
